248 related articles for article (PubMed ID: 17620960)
1. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
[TBL] [Abstract][Full Text] [Related]
2. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
[TBL] [Abstract][Full Text] [Related]
4. Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition.
Kobayashi N; Honda T; Yoshida K; Nakano S; Ohno T; Tsubokou Y; Matsuoka H
Atherosclerosis; 2006 Jul; 187(1):92-100. PubMed ID: 16214149
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effect of benidipine on cardiac performance and remodeling in failing rat hearts.
Ohno T; Kobayashi N; Yoshida K; Fukushima H; Matsuoka H
Am J Hypertens; 2008 Feb; 21(2):224-30. PubMed ID: 18188157
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
Nishio M; Sakata Y; Mano T; Yoshida J; Ohtani T; Takeda Y; Miwa T; Masuyama T; Yamamoto K; Hori M
J Hypertens; 2007 Feb; 25(2):455-61. PubMed ID: 17211254
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
[TBL] [Abstract][Full Text] [Related]
8. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats.
Mita S; Kobayashi N; Yoshida K; Nakano S; Matsuoka H
J Hypertens; 2005 Jan; 23(1):87-96. PubMed ID: 15643129
[TBL] [Abstract][Full Text] [Related]
10. Ramipril treatment protects against nitrate-induced oxidative stress in eNOS-/- mice: An implication of the NADPH oxidase pathway.
Otto A; Fontaine J; Berkenboom G
J Cardiovasc Pharmacol; 2006 Jul; 48(1):842-9. PubMed ID: 16891913
[TBL] [Abstract][Full Text] [Related]
11. Endothelial damage due to impaired nitric oxide bioavailability triggers cerebral aneurysm formation in female rats.
Tamura T; Jamous MA; Kitazato KT; Yagi K; Tada Y; Uno M; Nagahiro S
J Hypertens; 2009 Jun; 27(6):1284-92. PubMed ID: 19307983
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
J Pharmacol Exp Ther; 2011 Nov; 339(2):358-66. PubMed ID: 21807884
[TBL] [Abstract][Full Text] [Related]
13. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
[TBL] [Abstract][Full Text] [Related]
14. Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure.
Fukushima H; Kobayashi N; Takeshima H; Koguchi W; Ishimitsu T
J Cardiovasc Pharmacol; 2010 Jan; 55(1):83-8. PubMed ID: 19904215
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase.
Savoia C; Ebrahimian T; He Y; Gratton JP; Schiffrin EL; Touyz RM
J Hypertens; 2006 Dec; 24(12):2417-22. PubMed ID: 17082724
[TBL] [Abstract][Full Text] [Related]
16. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
[TBL] [Abstract][Full Text] [Related]
17. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Tokutomi Y; Matsuba S; Nako H; Nakagata N; Kaneko T; Ogawa H; Kim-Mitsuyama S
Hypertension; 2009 Sep; 54(3):633-8. PubMed ID: 19597038
[TBL] [Abstract][Full Text] [Related]
18. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
Dejima T; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Haku S; Kengo A; Masuda S; Shigenaga A; Azuma K; Matsuda M; Yabana M; Hirose T; Uchino K; Kimura K; Nagashima Y; Umemura S
J Hypertens; 2011 Oct; 29(10):1919-29. PubMed ID: 21844822
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats.
Ito N; Ohishi M; Yamamoto K; Tatara Y; Shiota A; Hayashi N; Komai N; Yanagitani Y; Rakugi H; Ogihara T
Am J Hypertens; 2007 Jul; 20(7):792-9. PubMed ID: 17586415
[TBL] [Abstract][Full Text] [Related]
20. Effects of the angiotensin II type 1 receptor antagonist valsartan on the expression of superoxide dismutase in hypertensive patients.
Yang HY; Kao PF; Chen TH; Tomlinson B; Ko WC; Chan P
J Clin Pharmacol; 2007 Mar; 47(3):397-403. PubMed ID: 17322151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
